Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma

Kelly R. Ostler, Qiwei Yang, Timothy J. Looney, Li Zhang, Aparna Vasanthakumar, Yufeng Tian, Masha Kocherginsky, Stacey L. Raimondi, Jessica G. DeMaio, Helen R. Salwen, Song Gu, Alexandre Chlenski, Arlene Naranjo, Amy Gill, Radhika Peddinti, Bruce T. Lahn, Susan L. Cohn, Lucy A. Godley

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Epigenetic changes in pediatric neuroblastoma may contribute to the aggressive pathophysiology of this disease, but little is known about the basis for such changes. In this study, we examined a role for the DNA methyltransferase DNMT3B, in particular, the truncated isoform DNMT3B7, which is generated frequently in cancer. To investigate if aberrant DNMT3B transcripts alter DNA methylation, gene expression, and phenotypic character in neuroblastoma, we measured DNMT3B expression in primary tumors. Higher levels of DNMT3B7 were detected in differentiated ganglioneuroblastomas compared to undifferentiated neuroblastomas, suggesting that expression of DNMT3B7 may induce a less aggressive clinical phenotype. To test this hypothesis, we investigated the effects of enforced DNMT3B7 expression in neuroblastoma cells, finding a significant inhibition of cell proliferation in vitro and angiogenesis and tumor growth in vivo. DNMT3B7-positive cells had higher levels of total genomic methylation and a dramatic decrease in expression of the FOS and JUN family members that comprise AP1 transcription factors. Consistent with an established antagonistic relationship between AP1 expression and retinoic acid receptor activity, increased differentiation was seen in the DNMT3B7-expressing neuroblastoma cells following treatment with all-trans retinoic acid (ATRA) compared to controls. Our results indicate that DNMT3B7 modifies the epigenome in neuroblastoma cells to induce changes in gene expression, inhibit tumor growth, and increase sensitivity to ATRA.

Original languageEnglish (US)
Pages (from-to)4714-4723
Number of pages10
JournalCancer Research
Volume72
Issue number18
DOIs
StatePublished - Sep 15 2012

Fingerprint

DNA Methylation
Neuroblastoma
Protein Isoforms
Growth
Tretinoin
Neoplasms
Ganglioneuroblastoma
Gene Expression
Retinoic Acid Receptors
Methyltransferases
Cerebral Palsy
Epigenomics
Methylation
Transcription Factors
Cell Proliferation
Pediatrics
Phenotype
DNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ostler, K. R., Yang, Q., Looney, T. J., Zhang, L., Vasanthakumar, A., Tian, Y., ... Godley, L. A. (2012). Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Research, 72(18), 4714-4723. https://doi.org/10.1158/0008-5472.CAN-12-0886

Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. / Ostler, Kelly R.; Yang, Qiwei; Looney, Timothy J.; Zhang, Li; Vasanthakumar, Aparna; Tian, Yufeng; Kocherginsky, Masha; Raimondi, Stacey L.; DeMaio, Jessica G.; Salwen, Helen R.; Gu, Song; Chlenski, Alexandre; Naranjo, Arlene; Gill, Amy; Peddinti, Radhika; Lahn, Bruce T.; Cohn, Susan L.; Godley, Lucy A.

In: Cancer Research, Vol. 72, No. 18, 15.09.2012, p. 4714-4723.

Research output: Contribution to journalArticle

Ostler, KR, Yang, Q, Looney, TJ, Zhang, L, Vasanthakumar, A, Tian, Y, Kocherginsky, M, Raimondi, SL, DeMaio, JG, Salwen, HR, Gu, S, Chlenski, A, Naranjo, A, Gill, A, Peddinti, R, Lahn, BT, Cohn, SL & Godley, LA 2012, 'Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma', Cancer Research, vol. 72, no. 18, pp. 4714-4723. https://doi.org/10.1158/0008-5472.CAN-12-0886
Ostler, Kelly R. ; Yang, Qiwei ; Looney, Timothy J. ; Zhang, Li ; Vasanthakumar, Aparna ; Tian, Yufeng ; Kocherginsky, Masha ; Raimondi, Stacey L. ; DeMaio, Jessica G. ; Salwen, Helen R. ; Gu, Song ; Chlenski, Alexandre ; Naranjo, Arlene ; Gill, Amy ; Peddinti, Radhika ; Lahn, Bruce T. ; Cohn, Susan L. ; Godley, Lucy A. / Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. In: Cancer Research. 2012 ; Vol. 72, No. 18. pp. 4714-4723.
@article{653b851725594c828c018ccc81763005,
title = "Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma",
abstract = "Epigenetic changes in pediatric neuroblastoma may contribute to the aggressive pathophysiology of this disease, but little is known about the basis for such changes. In this study, we examined a role for the DNA methyltransferase DNMT3B, in particular, the truncated isoform DNMT3B7, which is generated frequently in cancer. To investigate if aberrant DNMT3B transcripts alter DNA methylation, gene expression, and phenotypic character in neuroblastoma, we measured DNMT3B expression in primary tumors. Higher levels of DNMT3B7 were detected in differentiated ganglioneuroblastomas compared to undifferentiated neuroblastomas, suggesting that expression of DNMT3B7 may induce a less aggressive clinical phenotype. To test this hypothesis, we investigated the effects of enforced DNMT3B7 expression in neuroblastoma cells, finding a significant inhibition of cell proliferation in vitro and angiogenesis and tumor growth in vivo. DNMT3B7-positive cells had higher levels of total genomic methylation and a dramatic decrease in expression of the FOS and JUN family members that comprise AP1 transcription factors. Consistent with an established antagonistic relationship between AP1 expression and retinoic acid receptor activity, increased differentiation was seen in the DNMT3B7-expressing neuroblastoma cells following treatment with all-trans retinoic acid (ATRA) compared to controls. Our results indicate that DNMT3B7 modifies the epigenome in neuroblastoma cells to induce changes in gene expression, inhibit tumor growth, and increase sensitivity to ATRA.",
author = "Ostler, {Kelly R.} and Qiwei Yang and Looney, {Timothy J.} and Li Zhang and Aparna Vasanthakumar and Yufeng Tian and Masha Kocherginsky and Raimondi, {Stacey L.} and DeMaio, {Jessica G.} and Salwen, {Helen R.} and Song Gu and Alexandre Chlenski and Arlene Naranjo and Amy Gill and Radhika Peddinti and Lahn, {Bruce T.} and Cohn, {Susan L.} and Godley, {Lucy A.}",
year = "2012",
month = "9",
day = "15",
doi = "10.1158/0008-5472.CAN-12-0886",
language = "English (US)",
volume = "72",
pages = "4714--4723",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma

AU - Ostler, Kelly R.

AU - Yang, Qiwei

AU - Looney, Timothy J.

AU - Zhang, Li

AU - Vasanthakumar, Aparna

AU - Tian, Yufeng

AU - Kocherginsky, Masha

AU - Raimondi, Stacey L.

AU - DeMaio, Jessica G.

AU - Salwen, Helen R.

AU - Gu, Song

AU - Chlenski, Alexandre

AU - Naranjo, Arlene

AU - Gill, Amy

AU - Peddinti, Radhika

AU - Lahn, Bruce T.

AU - Cohn, Susan L.

AU - Godley, Lucy A.

PY - 2012/9/15

Y1 - 2012/9/15

N2 - Epigenetic changes in pediatric neuroblastoma may contribute to the aggressive pathophysiology of this disease, but little is known about the basis for such changes. In this study, we examined a role for the DNA methyltransferase DNMT3B, in particular, the truncated isoform DNMT3B7, which is generated frequently in cancer. To investigate if aberrant DNMT3B transcripts alter DNA methylation, gene expression, and phenotypic character in neuroblastoma, we measured DNMT3B expression in primary tumors. Higher levels of DNMT3B7 were detected in differentiated ganglioneuroblastomas compared to undifferentiated neuroblastomas, suggesting that expression of DNMT3B7 may induce a less aggressive clinical phenotype. To test this hypothesis, we investigated the effects of enforced DNMT3B7 expression in neuroblastoma cells, finding a significant inhibition of cell proliferation in vitro and angiogenesis and tumor growth in vivo. DNMT3B7-positive cells had higher levels of total genomic methylation and a dramatic decrease in expression of the FOS and JUN family members that comprise AP1 transcription factors. Consistent with an established antagonistic relationship between AP1 expression and retinoic acid receptor activity, increased differentiation was seen in the DNMT3B7-expressing neuroblastoma cells following treatment with all-trans retinoic acid (ATRA) compared to controls. Our results indicate that DNMT3B7 modifies the epigenome in neuroblastoma cells to induce changes in gene expression, inhibit tumor growth, and increase sensitivity to ATRA.

AB - Epigenetic changes in pediatric neuroblastoma may contribute to the aggressive pathophysiology of this disease, but little is known about the basis for such changes. In this study, we examined a role for the DNA methyltransferase DNMT3B, in particular, the truncated isoform DNMT3B7, which is generated frequently in cancer. To investigate if aberrant DNMT3B transcripts alter DNA methylation, gene expression, and phenotypic character in neuroblastoma, we measured DNMT3B expression in primary tumors. Higher levels of DNMT3B7 were detected in differentiated ganglioneuroblastomas compared to undifferentiated neuroblastomas, suggesting that expression of DNMT3B7 may induce a less aggressive clinical phenotype. To test this hypothesis, we investigated the effects of enforced DNMT3B7 expression in neuroblastoma cells, finding a significant inhibition of cell proliferation in vitro and angiogenesis and tumor growth in vivo. DNMT3B7-positive cells had higher levels of total genomic methylation and a dramatic decrease in expression of the FOS and JUN family members that comprise AP1 transcription factors. Consistent with an established antagonistic relationship between AP1 expression and retinoic acid receptor activity, increased differentiation was seen in the DNMT3B7-expressing neuroblastoma cells following treatment with all-trans retinoic acid (ATRA) compared to controls. Our results indicate that DNMT3B7 modifies the epigenome in neuroblastoma cells to induce changes in gene expression, inhibit tumor growth, and increase sensitivity to ATRA.

UR - http://www.scopus.com/inward/record.url?scp=84866390172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866390172&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-0886

DO - 10.1158/0008-5472.CAN-12-0886

M3 - Article

C2 - 22815530

AN - SCOPUS:84866390172

VL - 72

SP - 4714

EP - 4723

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 18

ER -